CClinicalTrials.gg
WithdrawnNCT05930834Updated Oct 1, 2024

Exercise Training and Insulin Sensitivity

An interventional study of exercise in Obesity and Exercise, sponsored by University of Missouri-Columbia. Withdrawn at 1 site in United States. Open to participants aged 21 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-01.

Sponsored by University of Missouri-Columbia · Not applicable, Interventional, and Basic science

Why this study was withdrawn
student collecting data not available
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
21 Years to 45 Years
Sex
All
01

Study summary

Regular exercise participation is known to reduce cardiometabolic disease risk but the impact that exercise training has on adipose tissue (AT) metabolism is poorly understood, particularly in humans. It is well established that exercise training improves whole-body glucose levels and increases insulin sensitivity, and this can occur within one or two weeks. These effects are usually due to adaptations in skeletal muscle, the tissue responsible for the majority of glucose disposal. However, many studies have now determined that exercise training also results in adaptations in AT that improve whole-body metabolic health by improving glucose uptake into the AT.

Skeletal muscle is thought to account for approximately 75-85% of glucose uptake , and this process is impaired in .individuals who are insulin-resistant state. It is postulated that the increased level of adiposity that accompanies severe obesity would result in higher dependency on AT for glucose uptake as the AT would be a bigger "sink". Thus the role of AT in inducing whole body insulin resistance is still unclear, particularly in individuals with obesity.

This study will examine the changes in AT glucose uptake before and after 4 weeks of exercise training in obese individuals and establish if there are sex differences.

02

Conditions studied

  • Obesity
  • Exercise

Browse trials for

03

In context

Insulin Resistance

1,960 studies on the registry are indexed under Insulin Resistance; 306 are open to participants now.

Browse Insulin Resistance studies →

Lead sponsor

University of Missouri-Columbia is the lead sponsor of 357 studies on the registry; 70 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 28 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • non-smokers, weight stable (\<4 kg) within the last 6 months will be recruited for this study.
  • sedentary (not engaged in planned physical activities and performing less than a total of 2 h of physical activity per week during the last 6 months) men and women whose BMI is classified as obese (>30 kg/m2).

Exclusion criteria

Exclusion Criteria:

  • cardiovascular disease, uncontrolled hypertension (no beta blockers), smokers, pregnant, have any recent changes in hormonal birth control, or on any medications known to impact metabolism.
  • All participants will be regular sleepers with a duration of 7-9 hours/night.
  • Subjects with orthopedic limitations will not be included.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Exercise

    All subjects will undergo exercise training for 4 wks. 45-60 min of exercise, 4 sessions/wk supervised, 1 session unsupervised. intensity 60% of VO2 max

    Behavioral: exercise

Interventions

  • Behavioralexercise

    All subjects will undergo exercise training for 4 wks. 45-60 min of exercise, 4 sessions/wk supervised, 1 session unsupervised. intensity 60% of VO2 max

06

What researchers measure

Primary outcomes

  1. GLUT4 protein expression

    protein expression

    Time frame: 4 weeks

  2. TB1CD4 protein expression

    TB1CD4 protein expression

    Time frame: 4 weeks

Secondary outcomes

  1. percent body fat

    Body fat will be measured using DEXA pre and post training

    Time frame: 4 weeks

07

Study locations

1 site
  • University of Misouri
    Columbia, Missouri 65211, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05930834
Lead sponsor
University of Missouri-Columbia
Responsible party
Jill Kanaley (Professor and Interim Chair, Nutrition and Exercise Physiology, University of Missouri-Columbia) — Principal investigator
First posted
Jul 5, 2023
Start date
Jul 1, 2024
Primary completion
Oct 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Oct 1, 2024

Study contacts

Jill Kanaley
principal investigator · University of Missouri-Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion